294 related articles for article (PubMed ID: 31502693)
1. Drug Transporters Expressed in the Human Placenta and Models for Studying Maternal-Fetal Drug Transfer.
Dallmann A; Liu XI; Burckart GJ; van den Anker J
J Clin Pharmacol; 2019 Sep; 59 Suppl 1(Suppl 1):S70-S81. PubMed ID: 31502693
[TBL] [Abstract][Full Text] [Related]
2. Methodological Approaches to Evaluate Fetal Drug Exposure.
Bouazza N; Foissac F; Hirt D; Urien S; Benaboud S; Lui G; Treluyer JM
Curr Pharm Des; 2019; 25(5):496-504. PubMed ID: 30892158
[TBL] [Abstract][Full Text] [Related]
3. Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.
De Sousa Mendes M; Hirt D; Vinot C; Valade E; Lui G; Pressiat C; Bouazza N; Foissac F; Blanche S; Lê MP; Peytavin G; Treluyer JM; Urien S; Benaboud S
Br J Clin Pharmacol; 2016 Apr; 81(4):646-57. PubMed ID: 26518984
[TBL] [Abstract][Full Text] [Related]
4. Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments.
Bukkems VE; van Hove H; Roelofsen D; Freriksen JJM; van Ewijk-Beneken Kolmer EWJ; Burger DM; van Drongelen J; Svensson EM; Greupink R; Colbers A
Clin Pharmacokinet; 2022 Aug; 61(8):1129-1141. PubMed ID: 35579825
[TBL] [Abstract][Full Text] [Related]
5. Predicting Human Fetal Drug Exposure Through Maternal-Fetal PBPK Modeling and In Vitro or Ex Vivo Studies.
Balhara A; Kumar AR; Unadkat JD
J Clin Pharmacol; 2022 Sep; 62 Suppl 1(Suppl 1):S94-S114. PubMed ID: 36106781
[TBL] [Abstract][Full Text] [Related]
6. Integration of Placental Transfer in a Fetal-Maternal Physiologically Based Pharmacokinetic Model to Characterize Acetaminophen Exposure and Metabolic Clearance in the Fetus.
Mian P; Allegaert K; Conings S; Annaert P; Tibboel D; Pfister M; van Calsteren K; van den Anker JN; Dallmann A
Clin Pharmacokinet; 2020 Jul; 59(7):911-925. PubMed ID: 32052378
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy in pregnancy; effect of ABC and SLC transporters on drug transport across the placenta and fetal drug exposure.
Staud F; Cerveny L; Ceckova M
J Drug Target; 2012 Nov; 20(9):736-63. PubMed ID: 22994411
[TBL] [Abstract][Full Text] [Related]
8. Prediction of Maternal and Fetal Acyclovir, Emtricitabine, Lamivudine, and Metformin Concentrations during Pregnancy Using a Physiologically Based Pharmacokinetic Modeling Approach.
Abduljalil K; Pansari A; Ning J; Jamei M
Clin Pharmacokinet; 2022 May; 61(5):725-748. PubMed ID: 35067869
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Various Approaches to Estimate Transplacental Clearance of Vancomycin for Predicting Fetal Concentrations using a Maternal-Fetal Physiologically Based Pharmacokinetic Model.
Yan Y; Wang Q; Wu W; Yi H; Xie F
Pharm Res; 2024 May; 41(5):899-910. PubMed ID: 38684563
[TBL] [Abstract][Full Text] [Related]
10. Antidepressants and Antipsychotics in Human Pregnancy: Transfer Across the Placenta and Opportunities for Modeling Studies.
Zheng L; Yang H; Dallmann A
J Clin Pharmacol; 2022 Sep; 62 Suppl 1():S115-S128. PubMed ID: 36106784
[TBL] [Abstract][Full Text] [Related]
11. Predicting fetal exposure of crizotinib during pregnancy: Combining human ex vivo placenta perfusion data with physiologically-based pharmacokinetic modeling.
Roelofsen D; van Hove H; Bukkems V; Russel F; Eliesen G; Greupink R
Toxicol In Vitro; 2022 Dec; 85():105471. PubMed ID: 36096459
[TBL] [Abstract][Full Text] [Related]
12. Prediction of Maternal and Fetoplacental Concentrations of Cefazolin, Cefuroxime, and Amoxicillin during Pregnancy Using Bottom-Up Physiologically Based Pharmacokinetic Models.
Abduljalil K; Ning J; Pansari A; Pan X; Jamei M
Drug Metab Dispos; 2022 Apr; 50(4):386-400. PubMed ID: 35046066
[TBL] [Abstract][Full Text] [Related]
13. Regulation of drug transporter expression and function in the placenta.
Staud F; Ceckova M
Expert Opin Drug Metab Toxicol; 2015 Apr; 11(4):533-55. PubMed ID: 25600150
[TBL] [Abstract][Full Text] [Related]
14. The role of the placenta in fetal exposure to xenobiotics: importance of membrane transporters and human models for transfer studies.
Prouillac C; Lecoeur S
Drug Metab Dispos; 2010 Oct; 38(10):1623-35. PubMed ID: 20606001
[TBL] [Abstract][Full Text] [Related]
15. An update on placental drug transport and its relevance to fetal drug exposure.
Mao Q; Chen X
Med Rev (2021); 2022 Oct; 2(5):501-511. PubMed ID: 37724167
[TBL] [Abstract][Full Text] [Related]
16. In vivo kinetic study of materno-fetal fatty acid transfer in obese and normal weight pregnant women.
Gázquez A; Prieto-Sánchez MT; Blanco-Carnero JE; van Harskamp D; Perazzolo S; Oosterink JE; Demmelmair H; Schierbeek H; Sengers BG; Lewis RM; van Goudoever JB; Koletzko B; Larqué E
J Physiol; 2019 Oct; 597(19):4959-4973. PubMed ID: 31287560
[TBL] [Abstract][Full Text] [Related]
17. Placental drug transporters.
Unadkat JD; Dahlin A; Vijay S
Curr Drug Metab; 2004 Feb; 5(1):125-31. PubMed ID: 14965255
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic Coupling of a Novel
Mian P; Nolan B; van den Anker JN; van Calsteren K; Allegaert K; Lakhi N; Dallmann A
Front Pediatr; 2021; 9():733520. PubMed ID: 34631628
[TBL] [Abstract][Full Text] [Related]
19. Overview of Drug Transporters in Human Placenta.
Yamashita M; Markert UR
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884954
[TBL] [Abstract][Full Text] [Related]
20. Development of a Pharmacokinetic Model of Transplacental Transfer of Metformin to Predict In Vivo Fetal Exposure.
Kurosawa K; Chiba K; Noguchi S; Nishimura T; Tomi M
Drug Metab Dispos; 2020 Dec; 48(12):1293-1302. PubMed ID: 33051249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
